It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

PLATELET COUNT RESPONSE TO HELICOBACTER PYLORI ERADICATION IN IRANIAN ‎PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC ‎PURPURA | Zare | Mediterranean Journal of Hematology and Infectious Diseases

PLATELET COUNT RESPONSE TO HELICOBACTER PYLORI ERADICATION IN IRANIAN ‎PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC ‎PURPURA

Mohammad Erfan Zare

Abstract


Idiopathic thrombocytopenic purpura (ITP) is an autoimmune hematological disordercharacterized by auto antibody-mediated platelet destruction. Although the main cause of ITPremains unclear, but its relationship with some infection was demonstrated. In recent years, many studies have demonstrated improvement of platelet counts in ITP patients after treating Helicobacter pylori infection. The aim of this study was to investigate the effects of H. pylori eradication on platelet count response in Iranian ITP patients.A total of 26 patients diagnosed with both ITP and H. pylori infection. ITP were diagnosed whose platelet counts were less than 100×103/μL. These patients were tested for H. pylori infection by Urea Breath Test and serum H. pylori antibody. All patients received triple therapy for 7 or 14 days to eradicate H. pylori infection. These patients followed for six months.Prevalence of H. pylori was 67.3%. H. pylori eradication achieved in 89.5% (26/29). Of the 26 patients, 15 (57.7%) exhibited a complete response (CR) and 11 (42.3%) were unresponsive. We did not find partial responders. There was a significant difference in the baseline platelet count of responders and non-responders patients ( p<0.001). All responders had platelet count ≥50×103/μLand all non-responders had platelet count <50×103/μL.Results of this study revealed that eradication therapy of H. pylori infection can improve platelet counts in ITP patients especially with mild thrombocytopenia and support routine detection andtreatment of H. pylori infection in ITP patients in populations with a high prevalence of this infection.


Keywords


Bacterial Infection

References


‎1. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis 2008; ‎‎40: 490-6.‎

‎2. Menaker RJ, Sharaf AA, Jones NL. Helicobacter pylori infection and gastric cancer: host, bug, ‎environment, or all three? Curr Gastroenterol Rep 2004; 6(6):429-35.‎

‎3. Graham DY, Kimura K, Shimoyama T, Takemoto T. Helicobacter pylori infection in Japan: ‎current status and future options. Eur J Gastroenterol Hepatol 1994; (6 Suppl 1):S1-4.‎

‎4. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, ‎Cho SH, Oh BH. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007; ‎‎12:333-40.‎

‎5. Abadi AT, Taghvaei T, Mobarez AM, Carpenter BM, Merrell DS. Frequency of antibiotic ‎resistance in Helicobacter pylori strains isolated from the northern population of Iran. J Microbiol ‎‎2011; 49(6):987-93. ‎

‎6. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of ‎Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and ‎socioeconomic status. Gastroenterology 1991; 100:1495-501.‎

‎7. Hershko C, Ianculovich M, Souroujon M. A hematologist's view of unexplained iron ‎deficiency anemia in males: Impact of Helicobacter pylori eradication. Blood Cells Mol Dis 2007; ‎‎38(1):45-53.‎

‎8. Annibale B, Lahner E, Bordi C, Martino G, Caruana P, Grossi C, Negrini R, Delle Fave G. ‎Role of Helicobacter pylori infection in pernicious anaemia. Dig Liver Dis 2000; 32(9):756-62.‎

‎9. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of ‎autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352:878.‎

‎10. Hohmann AW, Booth K, Peters V, Gordon DL, Comacchio RM. Common epitope on HIV ‎p24 and human platelets. Lancet 1993; 342:1274-5.‎

‎11. Romero R, Kleinman RE. Thrombocytopenia associated with acute hepatitis B infection. ‎Pediatrics 1993; 91:150-2.‎

‎ ‎

‎12. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated ‎with hepatitis C viral infection. J Hepatol 1996; 24:135-40.‎

‎13. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic ‎thrombocytopenic purpura. Ann Intern Med 2004; 140:766-7.‎

‎14. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi ‎K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter ‎pylori CagA protein may be involved in the pathogenesis of H pylori-associated chronic ‎idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124:91-6.‎

‎15. Tag HS, Lee HS, Jung SH, Kim BK, Kim SB, Lee A, Lee JS, Shin SH, Kim YS. Effects of ‎Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J ‎Hematol 2010; 45(2):127-32. ‎

‎16. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, Volzone F, Jovic G, ‎Leonardi G, Donelli A, Torelli G. Helicobacter pylori infection and chronic immune ‎thrombocytopenic purpura: long-term results of bacterium eradication and association with ‎bacterium virulence profiles. Blood 2007; 110:3833-41.‎

‎17. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, Fujita M, Tamura T, Yokota K, ‎Oguma K, Okada H, Shiratori Y. Eradication of Helicobacter pylori increases platelet count in ‎patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35:214-219.‎

‎18. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda ‎K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y. Is eradication ‎therapy useful as the first line of treatment in Helicobacter pylori positive idiopathic ‎thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol ‎‎2005; 81:162-168.‎

‎19. Ahn ER, Tiede MP, Jy W, Bidot CJ, Fontana V, Ahn YS. Platelet activation in Helicobacter ‎pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but ‎seldom improves platelet counts. Acta Haematol 2006; 116:19-24.‎

‎20. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori ‎eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med ‎‎2005; 118:414-9.‎

‎21. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, ‎Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. ‎Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the ‎American Society of Hematology. Blood 1996; 88:3-40.‎

‎22. Jackson SC, Beck P, Buret AG, O'Connor PM, Meddings J, Pineo G, Poon MC. Long term ‎platelet responses to Helicobacter pylori eradication in Canadian patients with immune ‎thrombocytopenic purpura. Int J Hematol 2008; 88(2):212-8. ‎

‎23. Logan RP, Walker MM. ABC of the upper gastrointestinal tract: Epidemiology and diagnosis ‎of Helicobacter pylori infection. Bmj 2001; 323:920-922.‎

‎24Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas ‎T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection – ‎The Maastricht III Consensus Report. Gut 2007; 56:772–81.‎

‎25. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylorus initiate or ‎perpetuate immune thrombocytopenic purpura? Blood 2004; 103:890-6.‎

‎26. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, Yoshihara M, Fujimura K, ‎Chayama K. Immune response to CagA protein is associated with improved platelet count after ‎Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. ‎Helicobacter 2007; 12(1):36-42.‎

‎27. Kim JW, Kim JG, Chae SL, Cha YJ, Park SM. High prevalence of multiple strain ‎colonization of Helicobacter pylori in Korean patients: DNA diversity among clinical isolates ‎from the gastric corpus, antrum and duodenum. Korean J Intern Med 2004; 19(1):1-9.‎

‎28. Molaei M, Foroughi F, Mashayekhi R, Haghazali M, Zojaji H, Jafari F, Dabiri H, Zali MR. ‎CagA status and VacA subtypes of Helicobacter pylori in relation to histopathologic findings in ‎Iranian population. Indian J Pathol Microbiol 2010; 53(1):24-7.‎

‎29. Pérez-Pérez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, ‎Blaser MJ. Country-specific constancy by age in CagA+ proportion of Helicobacter pylori ‎infections. Int J Cancer 1997; 72:453-456.‎


Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.


Mediterr J Hematol Infect Dis ISSN 2035-3006